307 related articles for article (PubMed ID: 22891333)
41. Downregulation of the hedgehog receptor PTCH1 in colorectal serrated adenocarcinomas is not caused by PTCH1 mutations.
Stefanius K; Kantola T; Tuomisto A; Vahteristo P; Karttunen TJ; Aaltonen LA; Mäkinen MJ; Karhu A
Virchows Arch; 2011 Feb; 458(2):213-9. PubMed ID: 21234763
[TBL] [Abstract][Full Text] [Related]
42. Somatic mutation in mitochondrial DNA and nuclear microsatellite instability in gastric cancer.
Hiyama T; Tanaka S; Shima H; Kose K; Tuncel H; Ito M; Kitadai Y; Sumii M; Yoshihara M; Shimamoto F; Haruma K; Chayama K
Oncol Rep; 2003; 10(6):1837-41. PubMed ID: 14534705
[TBL] [Abstract][Full Text] [Related]
43. Association of somatic mutations in BRCA2 BRC domain with chemotherapy sensitivity and survival in high grade serous ovarian cancer.
Zhang G; Zhang J; Zhu Y; Liu H; Shi Y; Mi K; Li M; Zhao Q; Huang Z; Huang J
Exp Cell Res; 2021 Sep; 406(1):112742. PubMed ID: 34302857
[TBL] [Abstract][Full Text] [Related]
44. Somatic mutations of mitochondrial genome in hepatocellular carcinoma.
Yin PH; Wu CC; Lin JC; Chi CW; Wei YH; Lee HC
Mitochondrion; 2010 Mar; 10(2):174-82. PubMed ID: 20006738
[TBL] [Abstract][Full Text] [Related]
45. Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia.
Bentires-Alj M; Paez JG; David FS; Keilhack H; Halmos B; Naoki K; Maris JM; Richardson A; Bardelli A; Sugarbaker DJ; Richards WG; Du J; Girard L; Minna JD; Loh ML; Fisher DE; Velculescu VE; Vogelstein B; Meyerson M; Sellers WR; Neel BG
Cancer Res; 2004 Dec; 64(24):8816-20. PubMed ID: 15604238
[TBL] [Abstract][Full Text] [Related]
46. Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer.
Tan DJ; Bai RK; Wong LJ
Cancer Res; 2002 Feb; 62(4):972-6. PubMed ID: 11861366
[TBL] [Abstract][Full Text] [Related]
47. Next-Generation Sequencing of Matched Primary and Metastatic Rectal Adenocarcinomas Demonstrates Minimal Mutation Gain and Concordance to Colonic Adenocarcinomas.
Crumley SM; Pepper KL; Phan AT; Olsen RJ; Schwartz MR; Portier BP
Arch Pathol Lab Med; 2016 Jun; 140(6):529-35. PubMed ID: 26536055
[TBL] [Abstract][Full Text] [Related]
48. Mutational analysis of the tyrosine kinome in serous and clear cell endometrial cancer uncovers rare somatic mutations in TNK2 and DDR1.
Rudd ML; Mohamed H; Price JC; O'Hara AJ; Le Gallo M; Urick ME; ; Cruz P; Zhang S; Hansen NF; Godwin AK; Sgroi DC; Wolfsberg TG; Mullikin JC; Merino MJ; Bell DW
BMC Cancer; 2014 Nov; 14():884. PubMed ID: 25427824
[TBL] [Abstract][Full Text] [Related]
49. Molecular Alterations of TP53 are a Defining Feature of Ovarian High-Grade Serous Carcinoma: A Rereview of Cases Lacking TP53 Mutations in The Cancer Genome Atlas Ovarian Study.
Vang R; Levine DA; Soslow RA; Zaloudek C; Shih IeM; Kurman RJ
Int J Gynecol Pathol; 2016 Jan; 35(1):48-55. PubMed ID: 26166714
[TBL] [Abstract][Full Text] [Related]
50. Comparison of mitochondrial mutation spectra in ageing human colonic epithelium and disease: absence of evidence for purifying selection in somatic mitochondrial DNA point mutations.
Greaves LC; Elson JL; Nooteboom M; Grady JP; Taylor GA; Taylor RW; Mathers JC; Kirkwood TB; Turnbull DM
PLoS Genet; 2012; 8(11):e1003082. PubMed ID: 23166522
[TBL] [Abstract][Full Text] [Related]
51. Somatic mutations of mitochondrial DNA in aging and cancer progression.
Lee HC; Chang CM; Chi CW
Ageing Res Rev; 2010 Nov; 9 Suppl 1():S47-58. PubMed ID: 20816876
[TBL] [Abstract][Full Text] [Related]
52. Comprehensive mutation profiling by next-generation sequencing of effusion fluids from patients with high-grade serous ovarian carcinoma.
Shah RH; Scott SN; Brannon AR; Levine DA; Lin O; Berger MF
Cancer Cytopathol; 2015 May; 123(5):289-97. PubMed ID: 25655233
[TBL] [Abstract][Full Text] [Related]
53. [Mutations in the D-loop region of mitochondrial DNA in ovarian tumors].
Shi HH; Vincent L; Hextan N; Yang XY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Apr; 24(2):170-3. PubMed ID: 12905796
[TBL] [Abstract][Full Text] [Related]
54. Mitochondrial DNA mutations in breast cancer tissue and in matched nipple aspirate fluid.
Zhu W; Qin W; Bradley P; Wessel A; Puckett CL; Sauter ER
Carcinogenesis; 2005 Jan; 26(1):145-52. PubMed ID: 15375011
[TBL] [Abstract][Full Text] [Related]
55. Heteroplasmic shifts in tumor mitochondrial genomes reveal tissue-specific signals of relaxed and positive selection.
Grandhi S; Bosworth C; Maddox W; Sensiba C; Akhavanfard S; Ni Y; LaFramboise T
Hum Mol Genet; 2017 Aug; 26(15):2912-2922. PubMed ID: 28475717
[TBL] [Abstract][Full Text] [Related]
56. Recurrent KRAS codon 146 mutations in human colorectal cancer.
Edkins S; O'Meara S; Parker A; Stevens C; Reis M; Jones S; Greenman C; Davies H; Dalgliesh G; Forbes S; Hunter C; Smith R; Stephens P; Goldstraw P; Nicholson A; Chan TL; Velculescu VE; Yuen ST; Leung SY; Stratton MR; Futreal PA
Cancer Biol Ther; 2006 Aug; 5(8):928-32. PubMed ID: 16969076
[TBL] [Abstract][Full Text] [Related]
57. PIK3CA mutations in advanced ovarian carcinomas.
Wang Y; Helland A; Holm R; Kristensen GB; Børresen-Dale AL
Hum Mutat; 2005 Mar; 25(3):322. PubMed ID: 15712344
[TBL] [Abstract][Full Text] [Related]
58. Mitogenomic differences between the normal and tumor cells of colorectal cancer patients.
Skonieczna K; Malyarchuk B; Jawień A; Marszałek A; Banaszkiewicz Z; Jarmocik P; Grzybowski T
Hum Mutat; 2018 May; 39(5):691-701. PubMed ID: 29330893
[TBL] [Abstract][Full Text] [Related]
59. Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers.
Jazaeri AA; Yee CJ; Sotiriou C; Brantley KR; Boyd J; Liu ET
J Natl Cancer Inst; 2002 Jul; 94(13):990-1000. PubMed ID: 12096084
[TBL] [Abstract][Full Text] [Related]
60. Mitochondrial gene mutation, but not large-scale deletion, is a feature of colorectal carcinomas with mitochondrial microsatellite instability.
Habano W; Sugai T; Yoshida T; Nakamura S
Int J Cancer; 1999 Nov; 83(5):625-9. PubMed ID: 10521798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
